Medicare Advantage giant Humana reels
The health insurer has lost 24% in the week to data after it said the government is set to cut the rating on a large Medicare ...
Humana (HUM) was downgraded to underperform by BofA, which cited an ongoing delay in margin recovery amid news the company ...
Analyst Erin Wright of Morgan Stanley maintained a Hold rating on Humana (HUM – Research Report), with a price target of $374.00. Erin ...
Humana Inc.’s stock slid another 2.5% Thursday to bring its week-to-date losses to 24.4%, after BofA Securities downgraded it to underperform — or sell — on concerns about a delay in margin recovery.